A Phase I Study of ABT 510 for Newly Diagnosed Glioblastoma Multiforme
This study has been completed.
Sponsor:
University of Alabama at Birmingham
Information provided by (Responsible Party):
Louis Burt Nabors, MD, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT00584883
First received: December 26, 2007
Last updated: May 16, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2008 |
| Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |